SyntekaBio Inc (226330 KQ) stock market data APIs
₩5940
-50(-0.8%)
as of January 15, 2025
SyntekaBio Inc Financial Data Overview
Price chart is built with
Anychart
SyntekaBio, Inc. operates as a genomic big data and artificial intelligence drug discovery company. It creates new drug candidates using DeepMatcher, an AI drug development platform that combines new drug development technology and genomic big data technology, such as biomarkers for individual cancer drug screening and disease susceptibility by immunotyping, pharmacogenomic typing, and predicting multi-omics information-based drug adverse effects, etc. The company also developing new antigen prediction technology that can be used together with therapeutic vaccines and cell therapy products, and prediction of antibody therapeutics. SyntekaBio, Inc. was founded in 2009 and is headquartered in Daejeon, South Korea.
Prev. Close
5990
Open
5940
Volume
80 681
High
6070
Low
5850
52 wk Range
4195-13960
Market Cap
90 483 M
Shares Outstanding
15 259 K
Revenue
124 M
EPS
-174.1318
Beta
0.616
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get SyntekaBio Inc data using free add-ons & libraries
Get SyntekaBio Inc Fundamental Data
SyntekaBio Inc Fundamental data includes:
- Net Revenue: 124 M
- EBITDA: -10 724 551 680
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-09-30
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
SyntekaBio Inc News
New
2023 Trends in New Drug Development
The webinar features panelists from Columbia University, Janssen, Syntekabio (KOSDAQ:226330.KQ) and Auctus Capital New York, N.Y. —News Direct— Syntekabio, Inc. Syntekabio (KOSDAQ:226330.KQ)(226...
New Cloud Platform “STB CLOUD” Disrupts AI Drug Discovery Worldwide (KOSDAQ:226330.KQ)
A.I. in New Drug Discovery and Development Takes Center Stage at New York Health Forum (226330.KQ)
New York, NY —News Direct— Syntekabio, Inc. The 19th New York Health Forum, hosted by W Medical Strategy Group, celebrated its year end on Nov. 28 with a successful gathering of physicians, execu...
A.I. Drug Discovery Company Syntekabio (KOSDAQ:226330.KQ) to Explore Partnerships at the J.P. Morgan Healthcare Conference and Biotech Showcase™ 2023
New York, NY —News Direct— Syntekabio, Inc. Syntekabio (KOSDAQ:226330.KQ)(226330:KS), a global AI drug discovery and development company, will participate in the 41st annual J.P. Morgan Healthcar...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
